Lantheus Holdings (LNTH) Exchange Rate Effect (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Exchange Rate Effect of -$22000.0 for Q1 2026, down 121.57% year-over-year from $102000.0 in Q1 2025, and up 97.11% quarter-over-quarter from -$760000.0 in Q4 2025.
Lantheus Holdings (LNTH) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Exchange Rate Effect for 13 consecutive years, with -$22000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 121.57% year-over-year to -$22000.0; the TTM figure through Mar 2026 stood at -$173000.0 (up 89.62% YoY), while the FY2025 annual figure was -$49000.0, up 95.09% from the prior year.
- Exchange Rate Effect improved to -$22000.0 in Q1 2026 per LNTH's latest filing, from -$760000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $827000.0 in Q2 2025 and bottomed at -$1.0 million in Q4 2024.
- Historically, Exchange Rate Effect has averaged -$93562.5 across 5 years, with a median of -$83500.0 in 2022.
- On a YoY basis, Exchange Rate Effect climbed as much as 885.71% in 2024 and fell as far as 514.77% in 2024.
- Lantheus Holdings' Exchange Rate Effect stood at -$69000.0 in 2022, then tumbled by 236.23% to -$232000.0 in 2023, then plunged by 344.83% to -$1.0 million in 2024, then advanced by 26.36% to -$760000.0 in 2025, then jumped by 97.11% to -$22000.0 in 2026.
- Business Quant data shows LNTH's Exchange Rate Effect at -$22000.0 in Q1 2026, -$760000.0 in Q4 2025, and -$218000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 36,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36,000.00 |
| Jun 30, 2026 | 36,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Dec 31, 2025 | -760,000.00 |
| Dec 31, 2025 | -760,000.00 |
| Sep 30, 2025 | -218,000.00 |
| Sep 30, 2025 | -218,000.00 |
| Jun 30, 2025 | 827,000.00 |
| Jun 30, 2025 | 827,000.00 |
| Mar 31, 2025 | 102,000.00 |
| Mar 31, 2025 | 102,000.00 |
| Dec 31, 2024 | -1.03 Mn |
| Dec 31, 2024 | -1.03 Mn |
| Sep 30, 2024 | 247,000.00 |
| Sep 30, 2024 | 247,000.00 |
| Jun 30, 2024 | -983,000.00 |
| Jun 30, 2024 | -983,000.00 |
| Mar 31, 2024 | 770,000.00 |
| Mar 31, 2024 | 770,000.00 |